Nvidia (NASDAQ: NVDA ) stock fell 11% overnight as the stock rout accelerated. The shares were fighting to hold $94 before the market opened after closing Friday over $107.
Shares of NVIDIA ( NASDAQ: NVDA ) have surged by more than 450% in the last two years and added approximately 116% since the beginning of 2024.
Investors are understandably curious about buying the dip in Nvidia stock.
Reports show that Nvidia may be having issues with its upcoming AI chips.
Meta Platforms recently stated that it will continue to spend on AI infrastructure.
Nvidia ((NASDAQ: NVDA) shares have tumbled in early Monday trading, extending the stock's one-month decline to around 23%. This downturn comes amid a major pullback in global tech stocks and reports of a delay in the delivery of Nvidia's newly designed AI chips known as Blackwell.
With the Nasdaq heading for a 10% plunge, some analysts were telling clients not to panic and that they should use the market sell-off to go "bargain hunting". The US tech-powered stock exchange fell over 3% on Thursday and another 2.4% on Friday, with futures pointing to another 4.5% dive on Monday as Japan's Nikkei crashed 12.4% lower, Taiwan's benchmark down 7.5% and Europen benchmarks all fell over 2%.
Artificial intelligence stocks that have powered much of 2024's market gains dropped Monday as U.S. recession fears sparked a global sell-off on Wall Street.
Nvidia Corp.'s stock is falling hard in Monday's premarket action, partly reflecting concerns about reported delays for its new Blackwell chip and also taking into account general market weakness.
The tech rout on Wall Street appears to be alive and kicking, with semiconductor stocks particularly coming in for severe punishment. The tech wreck seen in the premarket on Monday is being led by artificial intelligence stalwart Nvidia Corp. NVDA.
The broader stock market downturn hasn't left the semiconductor giant Nvidia (NASDAQ: NVDA) stock unaffected, as it lost over 14% of its value in the previous month.
Nvidia shares have pulled back from recent highs, but Morgan Stanley remains bullish. The firm maintained an overweight rating on the shares with a $144 price target.